KPC Pharmaceuticals, Inc. (600422.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 9.55B |
| Enterprise Value | 10.43B |
| P/E Ratio | 60.95 |
| PEG Ratio | -0.73 |
| Price/Sales Ratio | 1.18 |
| Price/Book Ratio | 1.31 |
| Enterprise/Revenue | 1.42 |
| Enterprise/EBITDA | 27 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.02 |
| Operating Margin | 0.02 |
AD
Management Effectiveness
| Return On Assets | 0.01 |
| Return On Equity | 0.02 |
Income Statement
| Revenue | 6.58B |
| Revenue/Share | 7.67 |
| Gross Profit | 2.53B |
| EBITDA | 638.22M |
| Net Income | 349.94M |
| Diluted EPS | 0.46 |
Balance Sheet
| Total Cash | 1.62B |
| Total Cash/Share | 2.15 |
| Total Debt | 1.86B |
| Total Debt/Equity | 0.36 |
| Current Ratio | 2.09 |
| Book Value Per Share | 8.98 |
Price History
| 52-Week Change | -39.21 |
| 52-Week High | 15.08 |
| 52-Week Low | 7.45 |
| Moving Average 50 Days | 8.57 |
| Moving Average 200 Days | 11.21 |
Statistics
| Average Volume | 11.03M |
| Shares Outstanding | 756.98M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.18 |
| Trailing Annual Dividend Yield | 1.98 |
| Payout Ratio | 2.37 |
| Last Split Factor | 2:1 |
| Last Split Date | May 09, 2016 |
AD
